These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22274581)

  • 1. Association between survivin -31G > C promoter polymorphism and cancer risk: a meta-analysis.
    Wang X; Huang L; Xu Y; Shi Z; Wang Y; Zhang J; Wang X; Cao L; Luo H; Chen J; Liu N; Yin Y; You Y
    Eur J Hum Genet; 2012 Jul; 20(7):790-5. PubMed ID: 22274581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin promoter -31G/C (rs9904341) polymorphism and cancer susceptibility: a meta-analysis.
    Srivastava K; Srivastava A; Mittal B
    Mol Biol Rep; 2012 Feb; 39(2):1509-16. PubMed ID: 21611748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin rs9904341 (G>C) polymorphism contributes to cancer risk: an updated meta-analysis of 26 studies.
    Xu L; Zhou X; Xu L; Yin R
    Tumour Biol; 2014 Feb; 35(2):1661-9. PubMed ID: 24096544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between survivin -31G>C polymorphism and cancer risk: meta-analysis of 29 studies.
    Qin Q; Zhang C; Zhu H; Yang X; Xu L; Liu J; Lu J; Zhan L; Cheng H; Sun X
    J Cancer Res Clin Oncol; 2014 Feb; 140(2):179-88. PubMed ID: 24077840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study.
    Chen J; Cui X; Zhou H; Qin C; Cao Q; Ju X; Li P; Cai H; Zhu J; Meng X; Wang M; Zhang Z; Shao P; Li J; Yin C
    BMC Cancer; 2013 Jul; 13():356. PubMed ID: 23883402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin rs9904341 polymorphism significantly increased the risk of cancer: evidence from an updated meta-analysis of case-control studies.
    Moazeni-Roodi A; Ghavami S; Hashemi M
    Int J Clin Oncol; 2019 Apr; 24(4):335-349. PubMed ID: 30747314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population.
    Qin C; Cao Q; Li P; Ju X; Wang M; Chen J; Wu Y; Meng X; Zhu J; Zhang Z; Lu Q; Yin C
    PLoS One; 2012; 7(1):e28829. PubMed ID: 22295057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
    Rasool I; Afroze D; Wani KA; Yousuf A; Bhat IA; Rah B; Nazir SU; Hussain S; Dubey S
    Clin Breast Cancer; 2018 Aug; 18(4):e671-e676. PubMed ID: 29233639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin -31G>C polymorphism and gastrointestinal tract cancer risk: a meta-analysis.
    Liu Y; Li L; Qi H; Gao Y; Liu S; Xu C
    PLoS One; 2013; 8(2):e54081. PubMed ID: 23405077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population.
    Yang L; Zhu H; Zhou B; Gu H; Yan H; Tang N; Dong H; Sun Q; Cong R; Chen G; Wang B
    Dig Dis Sci; 2009 May; 54(5):1021-8. PubMed ID: 18716870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between survivin gene promoter -31G/C and -644C/T polymorphisms and non-small cell lung cancer.
    Aynaci E; Coskunpinar E; Eren A; Kum O; Oltulu YM; Akkaya N; Turna A; Yaylim I; Yildiz P
    Genet Mol Res; 2013 Feb; 12(3):3975-82. PubMed ID: 23479154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between survivin -31G>C polymorphism and susceptibility to sporadic colorectal cancer in a Southern Chinese population.
    Huang J; Wei Y; Zhou X; Wang L; Huang M; Wang J
    J Cancer Res Ther; 2019; 15(1):82-86. PubMed ID: 30880759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk.
    Liarmakopoulos E; Theodoropoulos G; Vaiopoulou A; Rizos S; Aravantinos G; Kouraklis G; Nikiteas N; Gazouli M
    Mol Med Rep; 2013 Mar; 7(3):887-92. PubMed ID: 23258739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between survivin genetic polymorphisms and lung cancer susceptibility.
    Guo G; Zhang Q; Yu Z; Li J; Ding Z; Li J; Tan W
    Int J Clin Exp Pathol; 2015; 8(6):7426-30. PubMed ID: 26261647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between rs20417 polymorphism in cyclooxygenase-2 and gastric cancer susceptibility: Evidence from15 case-control studies.
    Chen S; Chen L; Tan Y; Wang J
    Medicine (Baltimore); 2019 May; 98(18):e15468. PubMed ID: 31045826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin gene promoter polymorphism -31G/C as a risk factor for keratocystic odontogenic tumor development.
    Andric M; Nikolic N; Boskovic M; Milicic B; Skodric S; Basta Jovanovic G; Milasin J
    Eur J Oral Sci; 2012 Feb; 120(1):9-13. PubMed ID: 22288915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of polymorphism in the survivin gene promoter as a potential risk factor for head and neck cancers development.
    Kostić M; Nikolić N; Ilić B; Carkić J; Milenković S; Vukadinović M
    Srp Arh Celok Lek; 2013; 141(5-6):304-7. PubMed ID: 23858797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of survivin and its protein expression are associated with colorectal cancer susceptibility in Chinese population.
    Li XB; Li SN; Yang ZH; Cao L; Duan FL; Sun XW
    DNA Cell Biol; 2013 May; 32(5):236-42. PubMed ID: 23581553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the Ku70-1310C/G promoter polymorphism and cancer risk: a meta-analysis.
    Xu L; Ju XB; Li P; Wang J; Shi ZM; Zheng MJ; Xue DD; Xu YJ; Yin YM; Wang S; You YP
    Asian Pac J Cancer Prev; 2012; 13(2):683-7. PubMed ID: 22524845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among chinese.
    Ma F; Zhang H; Zhai Y; Huang W; Zhao C; Ou S; Zhou H; Yuan W; Wang Z; Wang H; Yue W; Yu L; Li P; Xia X; Cai M; Zhang Y; Cui Y; He F; Ma Y; Zhou G
    PLoS One; 2011 Feb; 6(2):e16748. PubMed ID: 21304814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.